financetom
Business
financetom
/
Business
/
Westgold Resources Books Higher Fiscal 2024 Net Profit
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Westgold Resources Books Higher Fiscal 2024 Net Profit
Aug 29, 2024 5:15 AM

07:24 AM EDT, 08/29/2024 (MT Newswires) -- Westgold Resources ( WGXRF ) said late on Wednesday that its net profit for the fiscal year ended June 30 jumped 852% as revenue rose 9%.

The company posted a net profit of A$95 million, or A$0.2011 per share, climbing from A$10 million, or A$0.0211 per share.

Revenue was up to A$716 million from A$657 million, reflecting the 23% increase in the achieved gold price and reduced hedging exposure.

Westgold's EBITDA improved 62% to A$271 million.

Westgold declared a fully franked final dividend of A$0.0125 per share bringing its total dividends for the fiscal year to A$0.0225 per share, a 12% free cash flow payout ratio.

"FY24 was a watershed year for Westgold with the company delivering significant improvement across key financial metrics," Managing Director and CEO Wayne Bramwell said.

"In FY24 Westgold found a balance between investing in our near-term growth options, maintaining balance sheet strength and delivering shareholder returns," Bramwell added.

The company's share price fell 2.6% yesterday to $2.63.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Colgate-Palmolive Q2 Non-GAAP Earnings, Net Sales Rise; 2024 Non-GAAP EPS Guidance Raised
Colgate-Palmolive Q2 Non-GAAP Earnings, Net Sales Rise; 2024 Non-GAAP EPS Guidance Raised
Jul 26, 2024
07:26 AM EDT, 07/26/2024 (MT Newswires) -- Colgate-Palmolive ( CL ) reported Q2 non-GAAP earnings Friday of $0.91 per diluted share, up from $0.77 a year earlier. Analysts polled by Capital IQ expected $0.87. Net sales for the quarter ended June 30 were $5.06 billion, up from $4.82 billion a year earlier. Analysts polled by Capital IQ expected $5.0 billion....
Canfor Q2 Adjusted Loss Widens on Write-down, Impairment Charges
Canfor Q2 Adjusted Loss Widens on Write-down, Impairment Charges
Jul 26, 2024
07:27 AM EDT, 07/26/2024 (MT Newswires) -- Canfor ( CFPZF ) , a lumber and wood producer, overnight Thursday reported a wider adjusted second-quarter loss on impairment and write-down charges and lack of economically viable fibre. The adjusted loss widened to $168.7 million, or $1.42 per share, from $44.3 million, or $0.36 last year. Inventory write-down, an asset write-down and...
Booz Allen Hamilton Fiscal Q1 Adjusted Earnings Fall, Revenue Rises; Fiscal 2025 Outlook Reaffirmed
Booz Allen Hamilton Fiscal Q1 Adjusted Earnings Fall, Revenue Rises; Fiscal 2025 Outlook Reaffirmed
Jul 26, 2024
07:31 AM EDT, 07/26/2024 (MT Newswires) -- Booz Allen Hamilton Holding ( BAH ) reported fiscal Q1 adjusted earnings Friday of $1.38 per diluted share, down from $1.47 a year earlier. Analysts polled by Capital IQ expected $1.52. Revenue for the quarter ended June 30 was $2.94 billion, compared with $2.65 billion a year earlier. Analysts surveyed by Capital IQ...
Akero Therapeutics Insider Sold Shares Worth $4,381,867, According to a Recent SEC Filing
Akero Therapeutics Insider Sold Shares Worth $4,381,867, According to a Recent SEC Filing
Jul 26, 2024
07:32 AM EDT, 07/26/2024 (MT Newswires) -- William Richard White, Chief Financial Officer, around July 23, 2024, sold 161,855 shares in Akero Therapeutics ( AKRO ) for $4,381,867. Following the Form 4 filing with the SEC, White has control over a total of 41,791 shares of the company, with 41,791 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1744659/000095017024086659/xslF345X03/ownership.xml ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved